tetano
Editor, Senior Moderator
Disaster Med Public Health Prep. 2011 Dec;5(4):253-255.
CDC's 2009 H1N1 Vaccine Pharmacy Initiative in the United States: Implications for Future Public Health and Pharmacy Collaborations for Emergency Response.
Koonin LM, Beauvais DR, Shimabukuro T, Wortley PM, Palmier JB, Stanley TR, Theofilos J, Merlin TL.
Source
Ms Koonin is Senior Advisor, Influenza Coordination Unit, Office of Infectious Diseases, Centers for Disease Control and Prevention; Ms Beauvais is Public Health Analyst, Influenza Coordination Unit, Office of Infectious Diseases, Centers for Disease Control and Prevention; Dr Shimabukuro is Senior Medical Officer, Immunization Safety Office, Centers for Disease Control and Prevention; Dr Wortley is Chief, Health Services Research & Evaluation Branch, Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; Ms Palmier is with the Institute of Public Health, Georgia State University; Atlanta, Georgia; Ms Stanley is Health Services Officer, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; Mr Theofilos is Lead, Capacity Building, Training, and Technical Assistance, Office of the Director, Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention; Dr Merlin is Director, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infections, Centers for Disease Control and Prevention.
PMID:
22146661
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22146661
CDC's 2009 H1N1 Vaccine Pharmacy Initiative in the United States: Implications for Future Public Health and Pharmacy Collaborations for Emergency Response.
Koonin LM, Beauvais DR, Shimabukuro T, Wortley PM, Palmier JB, Stanley TR, Theofilos J, Merlin TL.
Source
Ms Koonin is Senior Advisor, Influenza Coordination Unit, Office of Infectious Diseases, Centers for Disease Control and Prevention; Ms Beauvais is Public Health Analyst, Influenza Coordination Unit, Office of Infectious Diseases, Centers for Disease Control and Prevention; Dr Shimabukuro is Senior Medical Officer, Immunization Safety Office, Centers for Disease Control and Prevention; Dr Wortley is Chief, Health Services Research & Evaluation Branch, Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; Ms Palmier is with the Institute of Public Health, Georgia State University; Atlanta, Georgia; Ms Stanley is Health Services Officer, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; Mr Theofilos is Lead, Capacity Building, Training, and Technical Assistance, Office of the Director, Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention; Dr Merlin is Director, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infections, Centers for Disease Control and Prevention.
PMID:
22146661
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22146661